Second update on the possible use of CytoSorb in patients affected by COVID-19
Second update on the news related to the possible use of CytoSorb as an adjuvant therapy against some complications in patients with severe COVID-19 infection
Update on the possible use of CytoSorb in patients affected by COVID-19
We consider important to share an update on the news related to the possible use of CytoSorb as an adjuvant therapy against some complications in patients with severe infection with COVID-19
Possible use of CytoSorb in patients affected by COVID-19
In the recent days, we have witnessed the multiplication of cases of Covid-19 infection in Italy and Worldwide. Although this event should not be dramatized, we know that a percentage [...]
Against the Sepsis a new powerful ally
We are proud to announce that from today the fight against the Sepsis, the world's leading cause of hospital death, has a new ally.
Workshop “Purification Therapies – Ideas for Clinical Research”
Proceeding with the path started in January 2017, Aferetica announces the new edition of Workshop ‘Purification Therapies’ which will be held in Milan, at the Cariplo Centro Congressi, on March 15-16, 2019.
CytoSorb® Registry
CytoSorb® Registry is an independent international registry coordinated by the University Hospital of Jena and aimed at collecting data of all patients treated with CytoSorb®.
Official Video of the First Workshop “Purification Therapies”
Official Video of the First Workshop “Purification Therapies” is now online